SCOPUS 정보 검색 플랫폼

Neurologist

Volumn 13, Issue 3, 2007, Pages 164-167

Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy

(5) Tang, Junger a Wingerchuk, Dean M b Crum, Brian A a Rubin, Devon I c Demaerschalk, Bart M b,d,e

a MAYO CLINIC ROCHESTER (United States)

b MAYO CLINIC (United States)

c MAYO CLINIC (United States)

d MAYO CLINIC (United States)

e Cerebrovascular Diseases Center (United States)

Author keywords

Alpha lipoic acid; Critically appraised topic; Diabetic neuropathies; Evidence based medicine; Neuropathic pain; Thioctic acid

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; THIOCTIC ACID; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; NAUSEA; NEUROPATHIC PAIN; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOM; TREATMENT OUTCOME; VERTIGO; VOMITING;

ADMINISTRATION, ORAL; AGED; ANTIOXIDANTS; DIABETIC NEPHROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; MALE; META-ANALYSIS; SEVERITY OF ILLNESS INDEX; THIOCTIC ACID;

EID: 34248334200 PISSN: 10747931 EISSN: None Source Type: Journal
DOI: 10.1097/01.nrl.0000263703.78318.2b Document Type: Article

Times cited : (28)

References (6)

1
- 0032477332
- Symptomatic treatment of painful neuropathy
- Low PA. Symptomatic treatment of painful neuropathy. JAMA. 1998;280: 1863-1864.
- (1998) JAMA , vol.280 , pp. 1863-1864
- Low, P.A.¹

2
- 34248389758
- AltMedDex Editorial Staff; February
- AltMedDex Editorial Staff; MICROMEDEX, Alpha-lipoic acid; original publication December 1999, most recent revision March 2005; last accessed February 2007.
- (2007) MICROMEDEX, Alpha-lipoic acid; original publication December 1999, most recent revision March 2005; last accessed

3
- 33845499323
- Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: The SYDNEY 2 Trial
- Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 Trial. Diabetes Care. 2006;29:2365-2370.
- (2006) Diabetes Care , vol.29 , pp. 2365-2370
- Ziegler, D.¹ Ametov, A.² Barinov, A.³

4
- 1242337352
- Treatment of symptomatic diabetic polyneuropathy with antioxidant alpha-lipoic acid: A meta-analysis
- Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with antioxidant alpha-lipoic acid: a meta-analysis. Dia Diabet Med. 2004;21:114 -121.
- (2004) Dia Diabet Med , vol.21 , pp. 114-121
- Ziegler, D.¹ Nowak, H.² Kempler, P.³

5
- 0026764627
- The Rochester Diabetic Neuropathy Study: Reassessment of tests and criteria for diagnosis and staged severity
- Dyck PJ, Karnes JL, O'Brien PC, et al. The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology. 1992;42:1164-1170.
- (1992) Neurology , vol.42 , pp. 1164-1170
- Dyck, P.J.¹ Karnes, J.L.² O'Brien, P.C.³

6
- 29044433712
- The numbers needed to treat for neurological disorders
- Bussiere M, Wiebe S. The numbers needed to treat for neurological disorders. Can J Neurol Sci. 2005;32:440-449.
- (2005) Can J Neurol Sci , vol.32 , pp. 440-449
- Bussiere, M.¹ Wiebe, S.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.